0001752724-23-173311.txt : 20230814 0001752724-23-173311.hdr.sgml : 20230814 20230814082131 ACCESSION NUMBER: 0001752724-23-173311 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230531 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GUGGENHEIM STRATEGIC OPPORTUNITIES FUND CENTRAL INDEX KEY: 0001380936 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-21982 FILM NUMBER: 231166476 BUSINESS ADDRESS: STREET 1: 227 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-827-0100 MAIL ADDRESS: STREET 1: 227 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CLAYMORE/GUGGENHEIM STRATEGIC OPPORTUNITIES FUND DATE OF NAME CHANGE: 20090630 FORMER COMPANY: FORMER CONFORMED NAME: Claymore/Guggenheim Strategic Opportunities Fund DATE OF NAME CHANGE: 20070605 FORMER COMPANY: FORMER CONFORMED NAME: Claymore Strategic Opportunities Fund DATE OF NAME CHANGE: 20061113 N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001380936 XXXXXXXX 811-21982 false false false N-2 Guggenheim Strategic Opportunities Fund 811-21982 0001380936 549300ZOXRKM68J8NB63 227 West Monroe Street Chicago 60606 US-IL US 312-827-0100 MUFG Investor Services (US), LLC 805 King Farm Blvd Rockville 20850 240-614-4800 Records of the Trust"s securities and cash N N N-2 Y Randall C. Barnes 004411270 N Sandra G. Sponem N/A N Ronald E. Toupin, Jr. N/A N Angela Brock-Kyle N/A N Thomas F. Lydon Jr. 001099080 N Amy J. Lee 001161869 Y Ronald A. Nyberg N/A N Joanna Catalucci 004148421 227 West Monroe St Chicago 60606 XXXXXX N N N N N Cantor Fitzgerald & Co. 008-00201 000000134 5493004J7H4GCPG6OB62 N N Ernst & Young LLP 42 N/A N N N N N N Guggenheim Strategic Opportunities Fund 549300ZOXRKM68J8NB63 N N/A N N N N N/A N/A N/A Rule 18f-4 (17 CFR 270.18f-4) Rule 18f-4(d)(i) (17 CFR 270.18f-4(d)(i)) Rule 18f-4(e) (17 CFR 270.18f-4(e)) Rule 32a-4 (17 CFR 270.32a-4) Rule 17a-7 (17 CFR 270.17a-7) Rule 18f-4(f)(17 CFR 270.18f-4(f)) Y Y N N Guggenheim Funds Investment Advisors, LLC 801-62515 000129288 5493006FBKA0W3QZI223 N Guggenheim Partners Advisors, LLC 801-107511 000283238 N/A Y N Guggenheim Partners Advisors, LLC 801-107511 000283238 N/A 2022-12-22 Computershare Inc. 084-05925 254900Y7PP3ZED9AUY94 N N N Markit Ltd. 549300HLPTRASHS0E726 GB N Bloomberg 549300B56MD0ZC402L06 N Refinitiv US LLC 213800HQORQAP68CJJ04 N ICE Data Services 5493000NQ9LYLDBCTL34 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Computershare Inc. 254900Y7PP3ZED9AUY94 N N N MUFG Investor Services (US), LLC 084-05475 SEC File Number N N N Guggenheim Partners Middle East Limited N/A N/A N/A AE 0.00000000 GUGGENHEIM SECURITIES, LLC 8-49107 000040638 5493005G25VHYWLYJU59 0.00000000 Sammons Financial Network LLC 8-68905 000158538 N/A 0.00000000 Guggenheim Investor Services, LLC 8-44742 000030096 N/A 0.00000000 Guggenheim Funds Distributors, LLC 8-48842 000039805 549300YLHACOJHH3DN20 0.00000000 Guggenheim Partners Japan, Ltd. N/A N/A N/A JP 0.00000000 Guggenheim Securities International Ltd N/A N/A N/A GB 0.00000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 8890.79000000 J.P. MORGAN SECURITIES LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 309.54000000 BOFA SECURITIES, INC. 8-69787 000283942 549300HN4UKV1E2R3U73 1105.79000000 Instinet, LLC 8-23669 000007897 549300MGMN3RKMU8FT57 16231.56000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 4014.21000000 BNP PARIBAS SECURITIES CORP. 8-32682 000015794 2J5703FH5U5M97R1I237 105059.39000000 BLOOMBERG TRADEBOOK LLC 8-49219 000040881 549300P0PVQNO43T7K36 259.31000000 BNP Paribas Prime Brokerage International, Ltd. N/A N/A 5493000EGBAKFHIIT563 KY 1992.62000000 BARCLAYS CAPITAL INC. 8-41342 000019714 AC28XWWI3WIBK2824319 114.5400000 137977.75000000 BOFA SECURITIES, INC. 8-69787 000283942 549300HN4UKV1E2R3U73 648783507.15000000 J.P. MORGAN SECURITIES LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 307309066.81000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 391898782.93000000 CREDIT SUISSE SECURITIES (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 76356107.16000000 GOLDMAN SACHS & CO. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 172804813.55000000 BARCLAYS CAPITAL INC. 8-41342 000019714 AC28XWWI3WIBK2824319 345542672.25000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 412568358.81000000 RBC Capital Markets, LLC 8-45411 000031194 549300LCO2FLSSVFFR64 379725508.72000000 BNP Paribas Securities Corp. 8-32682 000015794 RCNB6OTYUAMMP879YW96 280223493.68000000 CREDIT SUISSE INTERNATIONAL N/A N/A E58DKGMJYYYJLN8C3868 GB 135973102.93000000 3466371718.04000000 N 1450941016.53417000 0.00000000 Common stock Common stock N N N N N N 1.29000000 2.88000000 15.69000000 12.34000000 false false true false false false false false false false false INTERNAL CONTROL RPT 2 Auditlettergof.htm AUDIT LETTER

 

Ernst & Young LLP

1775 Tysons Blvd.

Tysons, VA 22102

 

Tel: +1 703 747 0000

Fax: +1 703 747 1000

ey.com

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and

Board of Trustees of Guggenheim Strategic Opportunities Fund

 

In planning and performing our audit of the financial statements of Guggenheim Strategic Opportunities Fund (the “Fund”) as of and for the year ended May 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

 

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of May 31, 2023.

 

This report is intended solely for the information and use of management and the Board of Trustees of Guggenheim Strategic Opportunities Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

 

/s/ Ernst & Young LLP

 

Tysons, Virginia

July 25, 2023

 

A member firm of Ernst & Young Global Limited